Page last updated: 2024-09-05

symmetric dimethylarginine and Lymphoma, Non-Hodgkin

symmetric dimethylarginine has been researched along with Lymphoma, Non-Hodgkin in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Biedroń, M; Butrym, A; Chachaj, A; Fleszar, MG; Gamian, A; Karczewski, M; Krzystek-Korpacka, M; Mazur, G; Rybka, J; Szuba, A; Wiśniewski, J; Wróbel, T	1

Other Studies

1 other study(ies) available for symmetric dimethylarginine and Lymphoma, Non-Hodgkin

Article	Year
Asymmetric and symmetric dimethylarginines and mortality in patients with hematological malignancies-A prospective study. PloS one, 2018, Volume: 13, Issue:5 Topics: Adult; Aged; Aged, 80 and over; Arginine; Biomarkers, Tumor; Case-Control Studies; Female; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prognosis; Prospective Studies; Survival Rate; Young Adult	2018

Article

Year

Asymmetric and symmetric dimethylarginines and mortality in patients with hematological malignancies-A prospective study.

PloS one, 2018, Volume: 13, Issue:5

Topics: Adult; Aged; Aged, 80 and over; Arginine; Biomarkers, Tumor; Case-Control Studies; Female; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prognosis; Prospective Studies; Survival Rate; Young Adult

2018